Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 145 (RNA5SP145) is a member of the 5S rRNA pseudogene family, typically classified as a processed pseudogene[4]. While 5S rRNA is a 120-nucleotide essential structural RNA incorporated into ribosomes and required for normal protein translation in all cellular life forms except for mitochondrial ribosomes in animals and fungi[1][3], its pseudogenes, such as RNA5SP145, are defective, non-functional genomic sequences that arise from retrotransposition or duplication events but cannot produce a functional 5S rRNA molecule[4]. Processed rRNA pseudogenes like RNA5SP145 are not transcribed or involved in any known cellular mechanisms, have no protein product, and do not play a direct role in cellular biology, disease, or therapy. Key Points: - The correct canonical form is "RNA, 5S ribosomal pseudogene 145". - This is not a therapeutic target, gene, receptor, or enzyme; it is an rRNA pseudogene. - Pseudogenes such as RNA5SP145 may clutter genomic annotation sets but do not contribute to ribosome assembly or function and are not linked to diseases, drug action, or safety concerns[4]. - Its only molecular classification is as an "rRNA pseudogene" under "Other" (non-coding RNA pseudogenes). If you are seeking information on an actual ribosomal target with possible therapeutic significance, such as "5S ribosomal RNA" (not the pseudogene), please specify. 5S rRNA (the functional gene/product) is essential for ribosome structure and protein synthesis, but its pseudogenes, including RNA5SP145, are not functional and have no current clinical relevance[1][3][4].
None (no known mechanisms of drug action since it is not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 145 (RNA5SP145).